Psilera

About Psilera

Psilera is a biotechnology company focused on developing first-in-class treatments for neurological disorders by creating a new class of neuroplastogens. The company claims a best-in-class proprietary compound library with broad coverage and a leadership team with extensive experience in biotech and pharma. Its pipeline targets hard-to-treat CNS conditions, including Frontotemporal Dementia, and leverages a serotonergic compound framework to advance patient-centric therapies. Psilera operates in the neuroscience and drug discovery space, with research and development activities centered on neurological disease therapeutics.